Intelligence · Clinical Pipeline
Lakefront Biotherapeutics NV Pipeline
All ClinicalTrials.gov programs at Lakefront Biotherapeutics NV — phase, modality, and trial IDs.
- Programs
- 6
Quick answer
Lakefront Biotherapeutics NV has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Filgotinib
Lakefront Biotherapeutics NV
Crohn's Disease
2 trials -
Filgotinib
Lakefront Biotherapeutics NV
Ankylosing Spondylitis
3 trials -
Filgotinib
Lakefront Biotherapeutics NV
Psoriatic Arthritis
4 trials -
Filgotinib
Lakefront Biotherapeutics NV
Ulcerative Colitis
2 trials -
GLPG CAR T-cell therapy
Lakefront Biotherapeutics NV
Hematological Malignancies
1 trial -
GLPG1690
Lakefront Biotherapeutics NV
Idiopathic Pulmonary Fibrosis
2 trials
Frequently asked questions
How many pipeline programs does Lakefront Biotherapeutics NV have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs